ProShare Advisors
TBIO

ProShare Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

ProShare Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,907
Closed -$851K – 2380
2021
Q2 		$851K Buy
30,907
+2,407
+8% +$47.3K ﹤0.01% 1126
2021
Q1 		$470K Buy
28,500
+1,932
+7% +$44K ﹤0.01% 1485
2020
Q4 		$490K Buy
26,568
+6,248
+31% +$112K ﹤0.01% 1290
2020
Q3 		$277K Buy
20,320
+3,390
+20% +$52.3K ﹤0.01% 1228
2020
Q2 		$303K Buy
16,930
+6,640
+65% +$100K ﹤0.01% 1223
2020
Q1 		$103K Sell
10,290
-7,385
-42% -$60.5K ﹤0.01% 1077
2019
Q4 		$144K Buy
17,675
+522
+3% +$4.82K ﹤0.01% 1654
2019
Q3 		$170K Sell
17,153
-827
-5% -$7.81K ﹤0.01% 1469
2019
Q2 		$227K Sell
17,980
-564
-3% -$5.95K ﹤0.01% 1371
2019
Q1 		$189K Buy
18,544
+2,209
+14% +$16.9K ﹤0.01% 1487
2018
Q4 		$123K Buy
+16,335
New +$120K ﹤0.01% 1449

ProShare Advisors's TBIO Position: Q3 2021 in Review

ProShare Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 30,907 shares — an estimated $851K sold.

ProShare Advisors first reported a position in TBIO in Q4 2018 and held it in 11 quarters. The position peaked at $851K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • ProShare Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • ProShare Advisors sold 30,907 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $851K.
  • ProShare Advisors first reported a position in Translate Bio, Inc. Common Stock in Q4 2018 and held it in 11 quarters.
  • ProShare Advisors's Translate Bio, Inc. Common Stock position peaked at $851K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.